SinoMedic: HT Supreme drug-eluting stent system obtains registration certificate overseas.

Sinomed announced on June 5th that the company submitted the registration application materials for the company's HT Supreme drug-eluting stent system to the National Food and Drug Surveillance Institute of Colombia in 2023. The company recently received notification that the registration application materials for the HT Supreme drug-eluting stent system have been approved by INVIMA. This product is suitable for improving the coronary artery lumen diameter of patients with symptomatic heart disease caused by primary coronary artery lesions, with a reference vessel diameter of 2.25 mm to 5.00 mm.